首页> 外文期刊>The American Journal of Tropical Medicine and Hygiene >Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
【24h】

Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.

机译:简短报告:在Miltefosine治疗的内脏利什曼病中发生黑热病后皮肤利什曼病(PKDL)。

获取原文
获取原文并翻译 | 示例
           

摘要

We report two cases of post-kala-azar dermal leishmaniasis (PKDL), which had subsequently developed after successful treatment of visceral leishmaniasis with miltefosine. Both patients had maculo-nodular lesions all over the body, and they were diagnosed as PKDL by parasitologic examination for Leishmania donovani bodies in a skin snip of lesions. Patients were put on amphotericin B and responded very well for nodular lesions with one course of treatment. However, longer duration of the treatment is needed for total clearance of macular lesions from body surface in PKDL cases. This is the first case report of PKDL in India, which developed after successful treatment of visceral leishmaniasis with miltefosine.
机译:我们报告了两例黑热病后皮肤利什曼病(PKDL),其在用米替福辛成功治疗内脏利什曼病后发展。两名患者的全身都有黄斑状结节性病变,并且通过寄生虫学检查在病变皮肤的利什曼原虫中诊断为PKDL。患者使用两性霉素B治疗,一个疗程对结节性病变反应良好。但是,在PKDL病例中,需要更长的治疗时间才能从体表完全清除黄斑病变。这是印度PKDL的首例病例报告,该报告是在用米替福辛成功治疗内脏利什曼病后发展的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号